Clinical Trial Update: A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial update for SHR-A1811 injection in breast cancer (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN